Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance.

Autor: Azimi, A, Pernemalm, M, Frostvik Stolt, M, Hansson, J, Lehtiö, J, Egyházi Brage, S, Hertzman Johansson, C

Publikováno v: British Journal of Cancer; 5/13/2014, Vol. 110 Issue 10, p2489-2495, 7p

P2.04 Effects of Combined Exposure To Braf and Pi3K Inhibitors With Chemotherapeutic Agents

Autor: Egyhazi, S., Azimi, A., Ghasghgaei, S., Frostvik Stolt, M., Hertzman Johansson, C., Hansson, J.

Publikováno v: In Annals of Oncology June 2012 23 Supplement 5:v23-v23

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.

Autor: Azimi A; Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Tuominen R; Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Costa Svedman F; Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Caramuta S; Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Pernemalm M; Science for Life Laboratory, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Frostvik Stolt M; Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Kanter L; Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Kharaziha P; Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Lehtiö J; Science for Life Laboratory, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Hertzman Johansson C; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Höiom V; Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Hansson J; Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Egyhazi Brage S; Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Cell death & disease [Cell Death Dis] 2017 Aug 31; Vol. 8 (8), pp. e3029. Date of Electronic Publication: 2017 Aug 31.